Inverse PCR-Based RFLP Scanning Identifies Low-Level Mutation Signatures in Colon Cells and Tumors

Cancer Research

Volumn 64, Issue 7, 2004, Pages 2544-2551

  Liu, Wei Hua ^a   Kaur, Manjit ^a   Wang, Gang ^a   Zhu, Penny ^a   Zhang, Yuzhi ^a   Makrigiorgos, G Mike ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; GENE PRODUCT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN ATK3; PROTEIN BCL 2; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; COLON CANCER; COLON TUMOR; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC STABILITY; GENOME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INCIDENCE; INVERSE POLYMERASE CHAIN REACTION; METASTASIS; MISMATCH REPAIR; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BASE PAIR MISMATCH; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; GENOME, HUMAN; GENOMIC INSTABILITY; HCT116 CELLS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 1942474343     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3652     Document Type: Article

References (53)

1. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
2. Boland CR, Ricciardiello L. How many mutations does it take to make a tumor? Proc Natl Acad Sci USA 1999;96:14675-7.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
4. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
5. Stoler DL, Chen N, Basik M, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 1999;96:15121-6.
6. Jackson AL, Loeb LA. The mutation rate and cancer. Genetics 1998;148:1483-90.
7. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001;61:3230-9.
8. Kitano H. Tumor tactics. Nature 2003;420:125.
9. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-9.
10. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997;278:1054-9.
11. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
12. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 1994;91:6319-23.
13. Andrew SE, Reitmar AH, Fox J, Hsiao L, Francis A, McKinnon M, et al. Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice. Oncogene 1997;15:123-9.
14. Loeb LA, Christians FC. Multiple mutations in human cancers. Mutat Res 1996;350:279-86.
15. Marx J. Debate surges over the origin of genomic defects in cancer. Science 2002;297:544-6.
16. Umar A, Boyer JC, Thomas DC, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 1994;269:14367-70.
17. Bhattacharyya NP, Ganesh A, Phear G, Richards B, Skandalis A, Meuth M. Molecular analysis of mutations in mutator colorectal carcinoma cell lines. Hum Mol Genet. 1995;4:2057-64.
18. Glaab WE, Tindall KR. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 1997;18:1-8.
19. Parsons R, Li GM, Longley M, Modrich P, Liu B, Berk T, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995;268:738-40.
20. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 1994;6:273-81.
21. Malkhosyan S, McCarty A, Sawai H, Perucho M. Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype. Mutat Res 1996;316:249-59.
22. Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC. Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 1993;54:693-9.
23. Kaur M, Zhang Y, Liu WH, Tetradis S, Price BD, Makrigiorgos GM. Ligation of a primer at a mutation: a method to detect low level mutations in DNA. Mutagenesis 2002;17:365-74.
24. Liu WH, Kaur M, Makrigiorgos GM. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach. Hum Mutat 2003;21:535-41.
25. Warrens AN, Jones MD, Lechler RI. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 1997;186:29-35.
26. Pan KF, Liu W, Lu YY, et al. High throughput detection of microsatellite instability by denaturing high-performance liquid chromatography. Hum Mutat 2003;22:388-94.
27. Kim IJ, Shin Y, Kang HC, et al. Robust microsatellite instability (MSI) analysis by denaturing high-performance liquid chromatography (DHPLC). J Hum Genet 2003;48:525-30.
28. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
29. Roche-Lestienne C, Soenen-Cornu V, Grardel-Duflos N, et al. Several types of mutations of the Ab1 gene can be found in chronic myeloid leukemia patients resistant to ST1571, and they can pre-exist to the onset of treatment. Blood 2002;100:1014-8.
30. Hofmann WK, Komor M, Wassmann B, et al. Presence of the BCR-ABL mutation Glu255Lys prior to ST1571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia. Blood 2003;102:659-61
31. Kreuzer KA, Le Coutre P, Landt O, et al. Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique. Ann Hematol 2003;82:284-9.
32. Liu WH, Makrigiorgos GM. Sensitive and quantitative detection of mutations associated with clinical resistance to STI-571. Leuk Res 2003;27:979-82.
33. Luzzatto L, Melo JV. Acquired resistance to imatinib mesylate: selection for preexisting mutant cells. Blood 2002;100:1105.
34. Barthe C, Gharbi MJ, Lagarde V, et al. Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to ST1571. Br J Haematol 2002;119:109-11.
35. Gorre ME, Mohammed M, Ellwood K, et al., Clinical resistance to ST1-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876-80.
36. Peinado MA, Malkhosyan S, Velazquez A, Perucho M. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. Proc Natl Acad Sci USA 1992;89:10065-9.
37. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
38. Watanabe N, Okochi E, Hirayama Y, et al. Single nucleotide instability without microsatellite instability in rat mammary carcinomas. Cancer Res 2001;61:2632-40.
39. Okochi E, Watanabe N, Sugimura T, Ushijima T. Single nucleotide instability: a wide involvement in human and rat mammary carcinogenesis? Mutat Res 2002;506-507:101-11.
40. Malkhosyan S, Rampino N, Yamamoto H, Perucho M. Frameshift mutator mutations. Nature 1996;382:499-500.
41. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7.
42. Georgiades IB, Curtis LJ, Morris RM, Bird CC, Wyllie AH. Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene 1999;18:7933-40.
43. Goel A, Arnold CN, Niedzwiecki D, et al. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 2003;63:1608-14.
44. Eshleman JR, Donover PS, Littman SJ, et al. Increased transversions in a novel mutator colon cancer cell line. Oncogene 1998;16:1125-30.
45. Baranovskaya S, Soto JL, Perucho M, Malkhosyan SR. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci USA 2001;98:15107-12.
46. Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 2001;272:301-13.
47. Sandy MS, Chiocca SM, Cerutti PA. Genotypic analysis of mutations in Taq I restriction recognition sites by restriction fragment length polymorphism/polymerase chain reaction. Proc Natl Acad Sci USA 1992;89:890-4.
48. Pourzand C, Cerutti P. Genotypic mutation analysis by RFLP/PCR. Mutat Res 1993;288:113-21.
49. Mancuso T, Aguilar F, Pescarolo MP, Clerico L, Russo P, Parodi S. Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype. Nucleic Acids Res 1997;25:3643-8.
50. Cariello NF, Swenberg JA, Skopek TR. Fidelity of Thermococcus litoralis DNA polymerase (Vent) in PCR determined by denaturing gradient gel electrophoresis. Nucleic Acids Res 1991;19:4193-8.
51. Li-Sucholeiki XC, Thilly WG. A sensitive scanning technology for low frequency nuclear point mutations in human genomic DNA. Nucleic Acids Res 2000;28:E44.
52. Tomita-Mitchell A, Kat AG, Marcelino LA, Li-Sucholeiki XC, Goodluck-Griffith J, Thilly WG. Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene. Mutat Res 2000;450:125-38.
53. Tsao JL, Yatabe Y, Salovaara R, et al. Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci USA 2000;97:1236-41.